Skip to main content

Kymera Therapeutics, Inc.

KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001815442

In the last 90 days, Kymera Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 276 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Kymera Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
5 insiders, $33.5M in total
Insiders trading
5
Net value
−$33.5M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Kymera Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Kymera Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Adams BrianChief Legal Officer50,254Sep 4, 20262
Rooney TerenceChief Medical Officer38,000Jul 27, 20261
Mainolfi NelloChief Executive Officer666,568Jul 7, 202610
Jacobs Bruce N.Chief Financial Officer244,883Jul 2, 20264
Goodman NoahChief Business Officer47,179Jul 2, 20266
Booth BruceDirector462,856IndirectJul 2, 202612
Biotechnology Value Fund L PDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
BVF Partners L PDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
BVF IncDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
Biotechnology Value Fund II LPDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
Lampert Mark NDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
Biotechnology Value Trading Fund OS LPDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
BVF Partners OS Ltd.Director, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
BVF I GP LLCDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
BVF II GP LLCDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
BVF GP Holdings LLCDirector, Other: See Remarks and Footnotes78,787IndirectJun 26, 20262
Baker JulianDirector, 10% Owner7,955,916IndirectJun 25, 20262
Baker FelixDirector, 10% Owner7,955,916IndirectJun 25, 20262
Baker Bros. Advisors LPDirector, 10% Owner7,955,916IndirectJun 25, 20262
Baker Brothers Life Sciences LPDirector, 10% Owner7,955,916IndirectJun 25, 20262
667, L.P.Director, 10% Owner7,955,916IndirectJun 25, 20262
Baker Bros. Advisors (GP) LLCDirector, 10% Owner7,955,916IndirectJun 25, 20262
Maraganore JohnDirector–Jun 25, 20261
Sandor VictorDirector–Jun 25, 20261
Albers Jeffrey W.Director0Jun 25, 20263
Esposito PamelaDirector1,000Jun 25, 20266
Ridloff ElenaDirector0Jun 25, 20263
Hrustanovic GorjanDirector–Jun 25, 20261
Chadwick Jeremy GChief Operating Officer44,018May 27, 20267
Gollob JaredChief Medical Officer117,134Mar 4, 20264
Chiniara EllenChief Legal Officer80,085Mar 3, 20250
Morgan LeighDirector–Jun 20, 20240
Horobin JoannaDirector0Jun 7, 20240
Atlas Venture Fund X, L.P.10% Owner828,830IndirectMar 13, 20240
Atlas Venture Associates X, LLC10% Owner828,830IndirectMar 13, 20240
Atlas Venture Associates X, L.P.10% Owner828,830IndirectMar 13, 20240
Atlas Venture Opportunity Fund I, L.P.10% Owner828,830IndirectMar 13, 20240
Atlas Venture Associates Opportunity I, L.P.10% Owner828,830IndirectMar 13, 20240
Atlas Venture Associates Opportunity I, LLC10% Owner828,830IndirectMar 13, 20240
Caughey ElaineChief Business Officer18,986Mar 3, 20230
Nicholson Donald WilliamDirector–Jun 16, 20220
Chesworth RichardChief Scientific Officer0Aug 27, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 15, 2024 (view filing)Mar 141 dayBooth BruceDirectorSSale−154$41.51−$6.39K0.0%819.2K after10b5-1
May 23, 2024 (view filing)May 23Same dayChadwick Jeremy GChief Operating OfficerSSale−2.58K$34.99−$90.1K−5.5%44.2K after
Jun 7, 2024 (view filing)Jun 7Same dayHorobin JoannaDirectorSSale−8.50K$32.99−$280.4K−100.0%0 after2 lots10b5-1
Jun 14, 2024 (view filing)Jun 12-132 daysBooth BruceDirectorSSale−26.9K$35.27−$950.2K−3.2%802.0K after6 lots10b5-1
Jul 9, 2024 (view filing)Jul 9Same dayBooth BruceDirectorSSale−454.0K$38.21−$17.3M−38.6%723.2K after10 lots10b5-1
Jul 16, 2024 (view filing)Jul 15-161 dayGollob JaredChief Medical OfficerSSale−39.6K$45.53−$1.80M−29.3%95.5K after3 lots10b5-1
Aug 22, 2024 (view filing)4:03 PM ETAug 202 daysBaker Julian and 5 othersDirectorPPurchase+1$46.41+$46.410.0%5.52M after
Aug 22, 2024 (view filing)4:03 PM ETAug 211 dayBaker Julian and 5 othersDirectorPPurchase+2.59M$40.75+$105.7M–9.63M afterDerivative2 lots
Aug 22, 2024 (view filing)5:06 PM ETAug 202 daysBiotechnology Value Fund L P and 9 othersDirector, Other: See Remarks and FootnotesPPurchaseCommon Stock, $0.0001 par value+358.3K$40.75+$14.6M–156.7K afterDerivative2 lots
Aug 26, 2024 (view filing)Aug 26Same dayAlbers Jeffrey W.DirectorSSale−5.00K$49.10−$245.5K−100.0%0 after10b5-1
Sep 17, 2024 (view filing)Sep 17Same dayEsposito PamelaDirectorSSale−13.5K$48.28−$651.8K−100.0%0 after2 lots10b5-1
Dec 2, 2024 (view filing)Dec 2Same dayEsposito PamelaDirectorSSale−2.50K$49.00−$122.5K−100.0%0 after10b5-1
Jan 6, 2025 (view filing)Jan 6Same dayChiniara EllenChief Legal OfficerSSale−3.13K$41.75−$130.6K−5.4%54.8K after
Mar 3, 2025 (view filing)Mar 3Same dayGollob JaredChief Medical OfficerSSale−5.74K$30.45−$174.8K−4.6%120.0K after2 lots
Mar 3, 2025 (view filing)Mar 3Same dayJacobs Bruce N.Chief Financial OfficerSSale−7.04K$30.45−$214.2K−3.4%201.9K after2 lots
Mar 3, 2025 (view filing)Mar 3Same dayChadwick Jeremy GChief Operating OfficerSSale−1.38K$30.45−$42.1K−2.0%67.8K after2 lots
Mar 3, 2025 (view filing)Mar 3Same dayChiniara EllenChief Legal OfficerSSale−2.24K$30.45−$68.2K−2.7%80.1K after2 lots
May 23, 2025 (view filing)May 23Same dayChadwick Jeremy GChief Operating OfficerSSale−2.58K$29.30−$75.4K−3.7%66.4K after
Jun 3, 2025 (view filing)Jun 3Same dayAlbers Jeffrey W.DirectorSSale−6.35K$49.00−$311.1K−100.0%0 after10b5-1
Jun 3, 2025 (view filing)Jun 3Same dayMainolfi NelloChief Executive OfficerSSale−30.0K$49.00−$1.47M−4.3%660.5K after10b5-1
Jun 3, 2025 (view filing)Jun 3Same dayRidloff ElenaDirectorSSale−12.0K$46.10−$553.2K−100.0%0 after2 lots10b5-1
Jun 3, 2025 (view filing)Jun 3Same dayEsposito PamelaDirectorSSale−5.00K$49.04−$245.2K−100.0%0 after10b5-1
Jun 11, 2025 (view filing)Jun 11Same dayRidloff ElenaDirectorSSale−4.50K$50.00−$225.0K−100.0%0 after10b5-1
Jun 30, 2025 (view filing)8:15 PM ETJun 30Same dayBaker Julian and 5 othersDirectorPPurchase+655.5K$44.00+$28.8M+12.0%6.12M after2 lots
Jun 30, 2025 (view filing)8:15 PM ETJun 30Same dayBaker Julian and 5 othersDirectorPPurchase+655.5K$44.00+$28.8M–10.2M afterDerivative2 lots
Jul 1, 2025 (view filing)6:41 PM ETJun 301 dayBiotechnology Value Fund L P and 9 othersDirector, Other: See Remarks and FootnotesPPurchaseCommon Stock, $0.0001 par value+317.2K$44.00+$14.0M+875.1%353.4K after3 lots
Sep 16, 2025 (view filing)Sep 16Same dayMainolfi NelloChief Executive OfficerSSale−30.0K$49.00−$1.47M−4.3%660.5K after10b5-1
Sep 17, 2025 (view filing)Sep 17Same dayJacobs Bruce N.Chief Financial OfficerSSale−79.2K$50.00−$3.96M−25.8%227.4K after10b5-1
Oct 14, 2025 (view filing)Oct 131 dayAlbers Jeffrey W.DirectorSSale−5.00K$59.19−$295.9K−100.0%0 after10b5-1
Oct 14, 2025 (view filing)Oct 131 dayGollob JaredChief Medical OfficerSSale−3.11K$60.00−$186.8K−2.6%118.4K after10b5-1
Oct 15, 2025 (view filing)Oct 15Same dayGollob JaredChief Medical OfficerSSale−59.6K$61.42−$3.66M−35.1%110.0K after4 lots10b5-1
Oct 29, 2025 (view filing)Oct 29Same dayMainolfi NelloChief Executive OfficerSSale−30.0K$60.99−$1.83M−4.3%660.5K after3 lots10b5-1
Dec 8, 2025 (view filing)Dec 8Same dayGollob JaredChief Medical OfficerSSale−49.3K$88.66−$4.37M−31.0%110.0K after6 lots10b5-1
Dec 8, 2025 (view filing)Dec 8Same dayMainolfi NelloChief Executive OfficerSSale−100.0K$89.17−$8.92M−13.1%660.5K after10b5-1
Dec 8, 2025 (view filing)Dec 8Same dayAlbers Jeffrey W.DirectorSSale−5.00K$89.76−$448.8K−100.0%0 after2 lots10b5-1
Dec 11, 2025 (view filing)4:19 PM ETDec 11Same dayBaker Julian and 5 othersDirector, 10% OwnerPPurchase+2.01M$86.00+$172.5M+33.7%7.96M after2 lots
Dec 12, 2025 (view filing)Dec 10-122 daysBooth BruceDirectorSSale−236.6K$91.72−$21.7M−25.7%685.4K after14 lots
Dec 17, 2025 (view filing)Dec 17Same dayEsposito PamelaDirectorSSale−27.6K$82.16−$2.26M−100.0%0 after4 lots10b5-1
Dec 31, 2025 (view filing)Dec 31Same dayMainolfi NelloChief Executive OfficerSSale−30.0K$78.06−$2.34M−4.3%663.1K after2 lots10b5-1
Jan 20, 2026 (view filing)Jan 20Same dayEsposito PamelaDirectorSSale−5.50K$67.91−$373.5K−100.0%0 after3 lots10b5-1
Feb 20, 2026 (view filing)Feb 20Same dayEsposito PamelaDirectorSSale−2.50K$87.31−$218.3K−100.0%0 after2 lots10b5-1
Feb 25, 2026 (view filing)Feb 25Same dayMainolfi NelloChief Executive OfficerSSale−30.0K$90.26−$2.71M−4.3%666.2K after5 lots10b5-1
Mar 4, 2026 (view filing)Mar 2-42 daysJacobs Bruce N.Chief Financial OfficerSSale−12.5K$87.50−$1.09M−5.1%232.6K after7 lots
Mar 4, 2026 (view filing)Mar 2-42 daysGollob JaredChief Medical OfficerSSale−10.5K$87.24−$916.7K−8.2%117.1K after7 lots
Mar 4, 2026 (view filing)Mar 2-42 daysChadwick Jeremy GChief Operating OfficerSSale−5.96K$86.54−$515.6K−7.5%73.8K after7 lots
Mar 4, 2026 (view filing)Mar 22 daysBooth BruceDirectorSSale−81.9K$90.13−$7.38M−10.8%675.3K after2 lots10b5-1
Mar 11, 2026 (view filing)Mar 11Same dayChadwick Jeremy GChief Operating OfficerSSale−25.8K$83.30−$2.15M−27.5%68.1K after3 lots10b5-1
Mar 20, 2026 (view filing)Mar 20Same dayEsposito PamelaDirectorSSale−2.50K$79.15−$197.9K−100.0%0 after3 lots10b5-1
Mar 25, 2026 (view filing)Mar 23-252 daysChadwick Jeremy GChief Operating OfficerSSale−116.0K$78.02−$9.05M−65.5%61.2K after6 lots10b5-1
Apr 1, 2026 (view filing)Mar 31-Apr 11 dayChadwick Jeremy GChief Operating OfficerSSale−22.2K$85.43−$1.90M−26.7%61.2K after3 lots10b5-1